A rapid method for screening large numbers of environmental microorganisms for antiviral activity

Applied and Environmental Microbiology

Volumn 64, Issue 3, 1998, Pages 1161-1162

  Maullu, Carlo ^a   Lampis, Giorgio ^a   Deidda, Delia ^a   Petruzzelli, Sabrina ^a   Pompei, Raffaello ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 METHOXYPHENYL) 3 ACETATE 1,2,4 PENTATRIOLE; AGAR; ANTIVIRUS AGENT; KERALICIN; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL STRAIN; COLONY FORMATION; ENVIRONMENT; FECES; HUMAN; HUMAN CELL; MICROORGANISM; MONOLAYER CULTURE; NONHUMAN; SCREENING; SOIL; TECHNIQUE; VERO CELL; VIRUS INFECTION;

EID: 0031911291     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.64.3.1161-1162.1998     Document Type: Article

References (15)

1. Averett, D. R. 1989. Anti HIV compound assessment by two novel high capacity assays. J. Virol. Methods 23:263-276.
2. Baron, E. J., A. S. Weissfeld, P. A. Fuselier, and D. J. Brenner. 1995. Classification and identification of bacteria, p. 249-264. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
3. Giromes, R., J. T. Jofre, and A. Bosch. 1989. Isolation of marine bacteria with antiviral properties. Can. J. Microbiol. 35:1015-1021.
4. Kamei, Y., M. Yoshimizu, Y. Ezura, and T. Kimura. 1988. Screening of bacteria with antiviral activity from fresh water salmonid hatcheries. Microbiol. Immunol. 32:67-73.
5. Lampis, G., D. Deidda, C. Maullu, M. A. Madeddu, R. Pompei, F. Delle Monache, and G. Satta. 1995. Sattabacins and sattazolins: new biologically active compounds with antiviral properties extracted from a Bacillus sp. J. Antibiot. 48:967-972.
6. Lampis, G., D. Deidda, C. Maullu, M. A. Madeddu, R. Pompei, F. Delle Monache, and G. Satta. 1996. Karalicin, a new biologically active compound from Pseudomonas fluorescens/putida. I. Production, isolation, physico-chemical properties and structure elucidation. J. Antibiot. 49:260-262.
7. Lampis, G., D. Deidda, C. Maullu, M. A. Madeddu, R. Pompei, F. Delle Monache, and G. Satta. 1996. Karalicin, a new biologically active compound from Pseudomonas fluorescens/putida. II. Biological properties. J. Antibiot. 49:263-266.
8. Netzer, W. J. 1990. Emerging tools for discovering drugs. Biotechnology 8:618-622.
9. Omura, S. 1986. Philosophy of new drug discovery. Microbiol. Rev. 50:259-279.
10. Prusoff, W. H., T. S. Limand, and M. Zucker. 1986. Potential of targets for antiviral chemotherapy. Antivir. Res. 6:311-328.
11. Schwöbel, W., and G. Streissle. 1979. Attempts to standardize the screening for antiviral drugs by in vitro tests. Chemotherapy 25:268-278.
12. Silver, L., and K. Bostiam. 1990. Screening of natural products for antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 9:455-461.
13. Take, Y., T. Kubo, E. Takemori, Y. Inouye, and S. Nakamura. 1989. Biological properties of streptonigrin derivatives. III. In vitro and in vivo antiviral and antitumor activities. J. Antibiot. 42:968-976.
14. Talenti, A., and T. H. Smith. 1989. Screening with a shell vial assay for antiviral activity against cytomegalovirus. Diagn. Microbiol. Infect. Dis. 12:5-8.
15. Whitley, R. J., and C. A. Alford. 1978. Developmental aspects of selected antiviral chemotherapeutic agents. Annu. Rev. Microbiol. 32:285-300.